Dolutegravir and Lamivudine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
58437-027 -
Package NDC
58437-027-00 -
SPL ID
2cb08bda-e683-4918-a1c9-d4bb2140aa17
What the source publishes
- Labeler
- GlaxoSmithKline LLC
- Active ingredients
- Dolutegravir and Lamivudine
- Form
- TABLET, FILM COATED
- Administrative status
- present-in-source-snapshot
- Marketing status
- DRUG FOR FURTHER PROCESSING
- Product type
- DRUG FOR FURTHER PROCESSING
Names this record is found by
Complete source data
{
"name": "Dolutegravir and Lamivudine",
"splId": "2cb08bda-e683-4918-a1c9-d4bb2140aa17",
"labels": [],
"routes": [],
"labeler": "GlaxoSmithKline LLC",
"finished": false,
"packaging": [
{
"description": "38550 TABLET, FILM COATED in 1 DRUM (58437-027-00)",
"package_ndc": "58437-027-00",
"identifierStatus": "well-formed",
"marketing_start_date": "01-JAN-22"
}
],
"productId": "58437-027_2cb08bda-e683-4918-a1c9-d4bb2140aa17",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "58437-027",
"deaSchedule": null,
"genericName": "Dolutegravir and Lamivudine",
"productType": "DRUG FOR FURTHER PROCESSING",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DOLUTEGRAVIR SODIUM",
"strength": "50 mg/1"
},
{
"name": "LAMIVUDINE",
"strength": "300 mg/1"
}
],
"applicationNumber": null,
"marketingCategory": "DRUG FOR FURTHER PROCESSING",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220101",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:58437-027_2cb08bda-e683-4918-a1c9-d4bb2140aa17"